IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2019
Total Assets: $34.5M
Liabilities Breakdown FY2019
Total Liabilities: $893.0K
Asset Breakdown
Total Assets: $34.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $25.6M | 74.3% |
| Accounts Receivable | $84.0K | 0.2% |
| Inventory | $248.0K | 0.7% |
| Property, Plant & Equipment | $5.9M | 17.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $184.0K | 0.5% |
| Other Assets | $2.5M | 7.1% |
Liabilities Breakdown
Total Liabilities: $893.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $319.0K | 35.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $574.0K | 64.3% |